Try it
Microbiology · Mycology: Candida auris
Sample itemIn an ICU outbreak, several patients with central lines develop candidaemia. The yeast is identified as Candida haemulonii by a biochemical system, is resistant to fluconazole, and is cultured from bed rails and skin swabs. Which treatment is most appropriate initially?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. An echinocandin such as micafungin
Candida auris is often misidentified as C. haemulonii by older phenotypic systems, and is accurately identified by MALDI-TOF or sequencing. It is frequently multidrug resistant, colonises skin and persists on surfaces, so outbreaks need contact precautions and environmental cleaning. An echinocandin is recommended first-line therapy.
Option by option
A. An echinocandin such as micafungin (correct)
Correct. Echinocandins are the recommended initial therapy for C. auris candidaemia.
B. Oral nystatin suspension
Nystatin is not absorbed and has no role in bloodstream infection.
C. Fluconazole at a higher dose
Most C. auris isolates are resistant to fluconazole, so a higher dose is not a reliable fix.
D. Oral flucytosine alone
Flucytosine alone allows rapid emergence of resistance and is used only in combination.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Microbiology questions
- BacteriologyA patient has profuse painless watery 'rice-water' stools and rapid dehydration. The cau…
- Culture mediaThayer–Martin medium is used selectively to isolate which organism?
- Immunology and serologyWhich of the following is a non-treponemal test for syphilis?
- BacteriologyAlbert's stain is used to demonstrate which of the following?